期刊文献+

雷帕霉素对内皮祖细胞数量与功能的影响 被引量:1

Effects of rapamycin on number and activity of endothelial progenitor cells
暂未订购
导出
摘要 目的观察雷帕霉素对外周血内皮祖细胞(EPCs)数量与功能的影响。方法采用密度梯度离心法从外周血获得单个核细胞,将其接种在人纤维连接蛋白包被的培养板上,培养7天后收集贴壁细胞,加入不同浓度(1·0、2·0、5·0μg/ml)雷帕霉素分别培养6、12、24、48h。激光共聚焦显微镜鉴定,FITC-UEA-I和Dil-acLDL双染色阳性细胞为正在分化的EPCs,流式细胞仪检测其表面标志以进一步鉴定EPCs,并在倒置荧光显微镜下计数。然后分别采用MTT比色法、改良的Boyden小室、黏附能力测定实验和体外血管生成试剂盒来观察EPCs的增殖能力、迁移能力、黏附能力和体外血管形成能力。结果EPCs数量随雷帕霉素浓度与作用时间增加而减少,其增殖能力、迁移能力、黏附能力和体外血管形成能力亦随雷帕霉素浓度与作用时间增加而降低。结论雷帕霉素降低EPCs的数量、增殖能力、迁移能力、黏附能力和体外血管形成能力,并呈浓度和时间依赖性。 Objective To investigate the effects of rapamycin on the number and function of peripheral blood endothelial progenitor cells (EPCs). Methods Total mononuclear cells (MNCs) were isolated from peripheral blood by Ficoll density gradient centrifugation, and then the cells were plated on fibronectin-coated culture dishes. After 7-day culture, adherent cells were treated with raparnycin in a series of final concentrations of 1.0, 2. 0, 5.0μg/rnl for 6, 12, 24, and 48h. EPCs were identified as adherent cells double positive for DiLDL-uptake and lectin binding by direct fluorescent staining as demonstrated under a laser scanning confocal microscope. EPCs were further documented by demonstrating the expression of VEGFR-2, AC133 and CD34 with flow cytometry. EPCs proliferation and migration were assayed with MTT assay and modified Boyden chamber assay, respectively. EPCs adhesion assay was performed by replating them on fibronectin-coated dishes, and then adherent cells were counted. In vitro vasculogenesis activity was assayed by in vitro vasculogenesis kit. Results Incubation of isolated human MNCs with rapamycin resulted in a decrease in the number of EPCs, and rapamycin also decreased EPCs proliferative, migratory, adhesive and in vitro vasculogenesis capacity in both concentration and time dependent manners. Conclusion Raparnycin decreases the number, proliferative, migratory, adhesive and in vitro vasculogenesis capacity of EPCs.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2006年第4期316-318,共3页 Medical Journal of Chinese People's Liberation Army
关键词 雷帕霉素 内皮祖细胞 细胞培养 raparnycin endothelial progenitor cells cell culture
  • 相关文献

参考文献10

  • 1Ma PC,Blaszkowsky L,Bharti A et al.Circulating tumor cells and serum tumor biomarkers in small cell lung cancer.Anticancer Res,2003,23(1A):49
  • 2Mancuso P,Calleri A,Cassi C et al.Circulating endothelial cells as a novel marker of angiogenesis.Adv Exp Med Biol,2003,522(5):83
  • 3Hill JM,Zalos G,Halcox JP et al.Circulating endothelial progenitor cells,vascular function,and cardiovascular risk.N Engl J Med,2003,348(7):593
  • 4Kalka C,Masuda H,Takahashi T et al.Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.Proc Natl Acad Sci USA,2000,97(7):3422
  • 5Vasa M,Fichtlscherers,Aiche A et al.Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.Cir Res,2001,89(1):E1
  • 6Walter DH,Rittig K,Bahlmann FH et al.Statin therapy accelerates reendothelialization:a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells.Circulation,2002,105(25):3017
  • 7Tepper OM,Galiano DR,Capla JM et al.Human endothelial progenitor cells from type Ⅱ diabetics exhibit impaired proliferation,adhesion,and incorporation into vascular structures.Circulation,2002,106(22):2781
  • 8Folkman J.Angiogenesis in cancer,vascular,rheumatoid and other disease.Nat Med,1995,1(1):27
  • 9Guba M,von Breitenbuch P,Steinbauer M et al.Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis:involvement of vascular endothelial growth factor.Nat Med,2002,8(2):128
  • 10Butzal M,Loges S,Schweizer M et al.Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro.Exp Cell Res,2004,300(1):65

同被引文献15

  • 1王传平,朱敬松,宋静,万大国,冯德广.PTCA术后再狭窄不同介入方法治疗效果观察[J].医药论坛杂志,2006,27(3):50-51. 被引量:6
  • 2吴孟津,危当恒,王贵学,刘录山,唐朝君,王佐,唐朝克.低剪切应力促进基质细胞衍生因子1在动脉粥样硬化斑块中表达[J].中国动脉硬化杂志,2006,14(12):1028-1030. 被引量:9
  • 3Oberhoff M, Herdeg C, Baumbach A, et al. Stent-based antirestenotic coatings (Sirolimus/Paclitaxel) [J]. Catheter Cardiovasc Interv, 2002,55(3) :404 - 408.
  • 4Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery[J]. N Engl Med, 2003,349( 14): 1307- 1323.
  • 5Gleichmann M, Gillen C, Czardybon M, et al. Cloning and characterization of SDF- 1 gamma, a novel SDF- 1 chemokine transcript with developmentally regulated expression in the nervous system[J]. Eur J Neuro Sci, 2000,12 (6) :1857 - 1866.
  • 6Lubbe J, Sorg O, Male PJ, et al. Sirolimus-induced inflammatory papules with acquired reactive perforating collagenosis[ J]. Dermatology, 2008,216(3) : 239 - 242.
  • 7Miyazawa A, Tsujino I, Ako J, et al. Characterization of late incomplete stent apposition: a comparison among baremetal stents, intracoronary radiation and sirolimus-eluting stents[J]. Invasive Carcliol, 2007,19(12) :515 - 518.
  • 8Hausleiter J, Kastrati A, Mehilli J, et al. OSIRIS Investigators. Randomized, double-blind, placebo-controlled trial of oralsirolimus for restenosis prevention in patients with instent restenosis: the Oral Sirolimus to Inhibit Recurrent Instent Stenosis (OSIRIS) trial[J]. Circulation, 2004, 110 (7) :790 - 795.
  • 9Rodriguez AE, Granada JF, Rodriguez AM, et al. ORAR Ⅱ Investigators. Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the prospective, randomized oral rapamycin in Argentina (ORAR Ⅱ ) study [J].J Am Coll Cardio. 2006,47(8) : 1522 - 1529.
  • 10Abi Younes S, Sauty A, Mach F, et al. The stromal cellderived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques[J]. Circ Res, 2000,86(2) : 131 - 138.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部